Andreas Koulouris

-Consultant, Medical Oncologist, Thoracic Oncology Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden

Karolinska University Hospital has been my professional home since 2021, where I serve as a Medical Consultant, deeply immersed in the intricacies of oncology and clinical research. My tenure here, complemented by a concurrent PhD candidacy, has honed my acumen in academic writing and cancer research, leading to multiple publications in esteemed journals.

The intersection of my clinical expertise and research allows for innovative contributions to the field of medicine, particularly in the understanding of brain metastases. Our team's collaborative efforts have unveiled novel microRNA profiles, prognostic scores for lung cancer patients with CNS involvement with a view to advancing the frontier of targeted cancer therapies and enriching the scientific community's resources to combat this challenging disease.

In navigating the complexities of cancer treatment and research, Sir William Osler's words resonate: "Medicine is a science of uncertainty and an art of probability..."

DIPLOMAS AND TITLES:

2023 Recognition of specialist qualification in Sweden
2022 Specialty Certification in Medical Oncology (Hellas)
2021 2021 ESMO Examination Certificate (Awardee of the 2021 Best ESMO Examination with 94.8%)
2018 Diploma of the Hellenic Boards of Oncology Hellenic Society of Medical Oncology (HeSMO) 
2015 ATLS (“Advanced Trauma Life Support”)
2014 School of Medicine, University of Athens, Hellas (Grade: Excellence 9, 10/10)

• Ph.D. Candidate at Karolinska Institutet. Medical research title: “Evaluation of clinical and molecular variables and the development of prognostic tools in patients with advanced non-small cell lung cancer with brain metastases and targetable mutations.” (Sweden, since 2024)
• Participation in the VEAP8964 study: “An observational study to identify selection criteria for initiation of different first-line treatment options in NSCLC patients.” (MSD, Sweden, 2022)
• Reviewer of the scientific journals: "Frontiers in Immunology", “Journal of Clinical Medicine” (JCM), “International Journal of molecular sciences” (IJMC), “Journal of hepatocellular carcinoma”, “Medicina”, “Forum of Clinical Oncology” (FCO), and “Clinical Medicine Insights: Oncology”.
  Ph.D. candidate at the University of Crete. Medical research title: Correlations between detectable genetic mutations and the microbiota in plasma and stools with the recurrence risk of patients with colorectal carcinoma stage II & III. (Since 2019)
  Website and Social media executive on behalf of the HeSMO. (2019 - 2021)
  ESMO member, ESMO ID: 413683. (Since 2018)
  Participation in the REFINE post-approval trial at Hippokration University Hospital. (BAYER, 2018)
  Member of the Hellenic Group of Young Oncologists (HeGYO), a subgroup of HeSMO. (2016)
  Member of the Gastro-Intestinal Cancer Study Group (GIC-SG). (2016)
  Member of the Organization Committee for the 6th, 7th, and 8th Hellenic Student Oncology Meeting and coordinator of the workshops. (2012, 2013, 2014)
  Member of the Laboratory of Pharmacology, Faculty of Medicine, University of Athens. (2012)

Research interests include: lung cancer, colorectal cancer, hepatocellular cancer, brain metastatic disease, targeted treatment, immunotherapy, CAR T-cell therapy

• Medical instructor for medical students in the course “Clinical Medicine, specialization, surgery”, Karolinska University Hospital. (since 2021)
• Medical instructor for medical students of the University of Crete, University General Hospital of Heraklion. (2018-2021)
• Coordinating Doctor responsible for pre-med student education at Hippokration General Hospital, Atlantis project. (2017)
• Medical instructor for medical students of the University of Athens, Hippokration General Hospital. (2016-2018)